UK: Business Integration Malvern and Concept Life Sciences to Integrate Businesses
Malvern Panalytical and Concept Life Sciences announced a full business integration. The integration will expand the existing analytical instrument and service relationship (Amplify Analytics) to include the Chemistry and Biology services of CLS. Both entities are operating businesses within the Spectris plc Group.
Malvern/UK — The integration builds on the companies’ 2020 launch of Amplify Analytics — a range of flexible services designed to help pharmaceutical organizations identify new drug candidates and de-risk the process of developing robust formulations. The success of the collaboration has been demonstrated in the significant value delivered to clients, providing the insight needed to bring pharmaceutical products to market quickly and efficiently.
Although the union of the two businesses will bring new approaches to client support, the strong commitment of CLS to its existing clients remains unchanged. Mark Carnegie-Brown, President of CLS, confirmed: “We have made sure that there is a seamless transition to the Malvern Panalytical platform for all our clients, free from changes to key contacts and existing service and confidentiality agreements. Our clients should not notice any changes to how we interact with them, but they will see expanded access to all capabilities and expertise across Concept Life Sciences and Malvern Panalytical. Our excited and enthused combined teams are eager to explore the unique opportunities delivered by our integration.”